Facebook Linkedin RSS Twitter Youtube
Home 2024

FDA review

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease
News

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease

BMS to Acquire Karuna for $14B, Bolstering Neuro Pipeline
Drug Discovery

BMS to Acquire Karuna for $14B, Bolstering Neuro Pipeline

Insilico Gains FDA’s First Orphan Drug Designation for AI Candidate
Artificial Intelligence

Insilico Gains FDA’s First Orphan Drug Designation for AI Candidate

Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing
Drug Discovery

Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus
Drug Discovery

Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus

Mechanism Underpinning “Chemo-Brain” Identified, Points to Existing Drug as Potential Therapy
Cancer

Mechanism Underpinning “Chemo-Brain” Identified, Points to Existing Drug as Potential Therapy

Recombinant Proteins Benefit the Clinical Diagnostic Industry
Cancer

Recombinant Proteins Benefit the Clinical Diagnostic Industry

Precision Medicine Marshals Its Resources
Drug Discovery

Precision Medicine Marshals Its Resources

FDA Approves Bluebird Bio’s Lentiviral Gene Therapy to Treat Beta-Thalassemia
Genome Editing

FDA Approves Bluebird Bio’s Lentiviral Gene Therapy to Treat Beta-Thalassemia

Mathematical Modeling in Biopharma: More than the Sum of Its Parts
Bioprocessing

Mathematical Modeling in Biopharma: More than the Sum of Its Parts

123...10Page 1 of 10
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.